1. Home
  2. EWTX

EWTX

Edgewise Therapeutics Inc.

Logo Edgewise Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.

Founded: 2017 Country:
United States
United States
Employees: N/A City: BOULDER
Market Cap: 1.5B IPO Year: 2021
Target Price: $29.80 AVG Volume (30 days): 959.1K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.57 EPS Growth: N/A
52 Week Low/High: $5.12 - $20.69 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: